Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review
Mohammad Bagherniya, Valério Nobili, Christopher N. Blesso, et al.
Pharmacological Research (2017) Vol. 130, pp. 213-240
Closed Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

Protective effects of curcumin against traumatic brain injury
Danial Khayatan, Seyed Mehrad Razavi, Zahra Najafi Arab, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113621-113621
Open Access | Times Cited: 94
Polyphenols and atherosclerosis: A critical review of clinical effects on LDL oxidation
Ali Ahmadi, Tannaz Jamialahmadi, Amirhossein Sahebkar
Pharmacological Research (2022) Vol. 184, pp. 106414-106414
Closed Access | Times Cited: 71
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2488-2488
Open Access | Times Cited: 66
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, et al.
Pharmacological Research (2023) Vol. 189, pp. 106679-106679
Open Access | Times Cited: 42
Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence
Arrigo F.G. Cicero, Alessandro Colletti, Stefano Bellentani
Nutrients (2018) Vol. 10, Iss. 9, pp. 1153-1153
Open Access | Times Cited: 153
A recent update on the multifaceted health benefits associated with ginger and its bioactive components
Run-Hui Ma, Zhi‐Jing Ni, Yun-Yang Zhu, et al.
Food & Function (2020) Vol. 12, Iss. 2, pp. 519-542
Closed Access | Times Cited: 95
Poria cocus Wolf Extract Ameliorates Hepatic Steatosis through Regulation of Lipid Metabolism, Inhibition of ER Stress, and Activation of Autophagy via AMPK Activation
Ji‐Hyun Kim, Hyun A Sim, Dae Young Jung, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4801-4801
Open Access | Times Cited: 90
A review of pharmacological and pharmacokinetic properties of stachydrine
Fang Cheng, Yanxi Zhou, Miao Wang, et al.
Pharmacological Research (2020) Vol. 155, pp. 104755-104755
Closed Access | Times Cited: 83
Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application
Hangyu Li, Ren‐You Gan, Ao Shang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 77
A review of pharmacological and pharmacokinetic properties of Forsythiaside A
Lihong Gong, Cheng Wang, Honglin Zhou, et al.
Pharmacological Research (2021) Vol. 169, pp. 105690-105690
Closed Access | Times Cited: 69
The beneficial therapeutic effects of plant‐derived natural products for the treatment of sarcopenia
Mohammad Bagherniya, Atena Mahdavi, Nafiseh Shokri Mashhadi, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 6, pp. 2772-2790
Open Access | Times Cited: 68
Theaflavin Chemistry and Its Health Benefits
Zhiguo Shan, Muhammad Nisar, Mingxi Li, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 65
Dieckol: a brown algal phlorotannin with biological potential
Durairaj Karthick Rajan, Kannan Mohan, Shubing Zhang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111988-111988
Open Access | Times Cited: 58
Bioactive compounds modulating Toll-like 4 receptor (TLR4)-mediated inflammation: pathways involved and future perspectives
Karen Salve Coutinho‐Wolino, Patrícia Pereira Almeida, Denise Mafra, et al.
Nutrition Research (2022) Vol. 107, pp. 96-116
Open Access | Times Cited: 55
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
Kailin Yang, Junpeng Chen, Tianqing Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
Nutritional, phytochemical composition and potential health benefits of taro (Colocasia esculenta L.) leaves: A review
Swati Mitharwal, Ankur Kumar, Komal Chauhan, et al.
Food Chemistry (2022) Vol. 383, pp. 132406-132406
Closed Access | Times Cited: 51
Recent advances in nanogold as a promising nanocarrier for curcumin delivery
Ali Mahmoudi, Prashant Kesharwani, Muhammed Majeed, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 215, pp. 112481-112481
Closed Access | Times Cited: 47
Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases
Anjana Sajeev, Mangala Hegde, Sosmitha Girisa, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1185-1185
Open Access | Times Cited: 42
Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates
Noel Salvoza, Pablo J. Giraudi, Claudio Tiribelli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2764-2764
Open Access | Times Cited: 41
Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases
Niloufar Rahiman, Yuliya V. Markina, Prashant Kesharwani, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 264-286
Closed Access | Times Cited: 40
Resveratrol from Dietary Supplement to a Drug Candidate: An Assessment of Potential
Shivani Khattar, Sauban Ahmed Khan, Syed Amir Azam Zaidi, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 957-957
Open Access | Times Cited: 39
Aescin can alleviate NAFLD through Keap1-Nrf2 by activating antioxidant and autophagy
Hao Yu, Siru Yan, Meiyu Jin, et al.
Phytomedicine (2023) Vol. 113, pp. 154746-154746
Closed Access | Times Cited: 25
Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials
Armin Ebrahimzadeh, Shokouh Mohseni, Mohammad Safargar, et al.
Complementary Therapies in Medicine (2024) Vol. 80, pp. 103025-103025
Open Access | Times Cited: 15
Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway
Yan Yang, Wen Qiu, Jiyuan Xiao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Improvement of Lipid and Glucose Metabolism by Capsiate in Palmitic Acid-Treated HepG2 Cells via Activation of the AMPK/SIRT1 Signaling Pathway
Yufan Zang, Fan Li, Jihua Chen, et al.
Journal of Agricultural and Food Chemistry (2018) Vol. 66, Iss. 26, pp. 6772-6781
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top